Echo Street Capital Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
Echo Street Capital Management's BLUE Position: Q2 2021 in Review
Echo Street Capital Management sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 1,306 shares — an estimated $510K sold.
Echo Street Capital Management first reported a position in BLUE in Q1 2021 and held it in 1 quarter. The position peaked at $510K in Q1 2021. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.
- Echo Street Capital Management reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
- Echo Street Capital Management sold 1,306 bluebird bio shares in Q2 2021, an estimated $510K.
- Echo Street Capital Management first reported a position in bluebird bio in Q1 2021 and held it in 1 quarter.
- Echo Street Capital Management's bluebird bio position peaked at $510K in Q1 2021.
- 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.
Based on Echo Street Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.